The European Medicines Agency, as part of the ongoing EMA-EC collaboration to improve understanding of biosimilar medicines in the EU, has published the following educational materials:
- A video on biosimilars for the general public in the following EU languages: Dutch, French, German, Italian, Polish, Portuguese and Spanish. (EMA plans to publish further language versions at a later stage)
- Translations of the information guide on biosimilars for healthcare professionals into Dutch, French, German, Italian, Polish, Portuguese and Spanish. (Translations into the remaining EU languages are expected by October 2018, subject to EMA’s business continuity planning due to relocation)
Visit the EMA’s webpage on biosimilar medicines to access these resources, as well as a link to the Q&A for patients.